124 related articles for article (PubMed ID: 32773640)
1. The Clinical Utility of Molecular Testing in the Management of Thyroid Follicular Neoplasms (Bethesda IV Nodules).
Carty SE; Ohori NP; Hilko DA; McCoy KL; French EK; Manroa P; Morariu E; Sridharan S; Seethala RR; Yip L
Ann Surg; 2020 Oct; 272(4):621-627. PubMed ID: 32773640
[TBL] [Abstract][Full Text] [Related]
2. Molecular Testing Versus Diagnostic Lobectomy in Bethesda III/IV Thyroid Nodules: A Cost-Effectiveness Analysis.
Nicholson KJ; Roberts MS; McCoy KL; Carty SE; Yip L
Thyroid; 2019 Sep; 29(9):1237-1243. PubMed ID: 31407625
[No Abstract] [Full Text] [Related]
3. A clinical algorithm for fine-needle aspiration molecular testing effectively guides the appropriate extent of initial thyroidectomy.
Yip L; Wharry LI; Armstrong MJ; Silbermann A; McCoy KL; Stang MT; Ohori NP; LeBeau SO; Coyne C; Nikiforova MN; Bauman JE; Johnson JT; Tublin ME; Hodak SP; Nikiforov YE; Carty SE
Ann Surg; 2014 Jul; 260(1):163-8. PubMed ID: 24901361
[TBL] [Abstract][Full Text] [Related]
4. Is an Increase in Thyroid Nodule Volume a Risk Factor for Malignancy?
Nakamura H; Hirokawa M; Ota H; Kihara M; Miya A; Miyauchi A
Thyroid; 2015 Jul; 25(7):804-11. PubMed ID: 25872408
[TBL] [Abstract][Full Text] [Related]
5. The natural history of the benign thyroid nodule: what is the appropriate follow-up strategy?
Ajmal S; Rapoport S; Ramirez Batlle H; Mazzaglia PJ
J Am Coll Surg; 2015 Jun; 220(6):987-92. PubMed ID: 25667137
[TBL] [Abstract][Full Text] [Related]
6. Targeted Next Generation Sequencing with ThyroSeq v2.1 for Indeterminate Thyroid Nodules in Clinical Practice.
Witt RL
Del Med J; 2016 Dec; 88(12):366-372. PubMed ID: 29461717
[TBL] [Abstract][Full Text] [Related]
7. The McGill Thyroid Nodule Score's (MTNS+) role in the investigation of thyroid nodules with benign ultrasound guided fine needle aspiration biopsies: a retrospective review.
Khalife S; Bouhabel S; Forest VI; Hier MP; Rochon L; Tamilia M; Payne RJ
J Otolaryngol Head Neck Surg; 2016 May; 45(1):29. PubMed ID: 27142264
[TBL] [Abstract][Full Text] [Related]
8. ACR TI-RADS and ATA US scores are helpful for the management of thyroid nodules with indeterminate cytology.
Barbosa TLM; Junior COM; Graf H; Cavalvanti T; Trippia MA; da Silveira Ugino RT; de Oliveira GL; Granella VH; de Carvalho GA
BMC Endocr Disord; 2019 Oct; 19(1):112. PubMed ID: 31664992
[TBL] [Abstract][Full Text] [Related]
9. Comparison of malignancy rate in thyroid nodules with cytology of indeterminate follicular or indeterminate Hürthle cell neoplasm.
Sorrenti S; Trimboli P; Catania A; Ulisse S; De Antoni E; D'Armiento M
Thyroid; 2009 Apr; 19(4):355-60. PubMed ID: 19355826
[TBL] [Abstract][Full Text] [Related]
10. Association of Tumor Size With Histologic and Clinical Outcomes Among Patients With Cytologically Indeterminate Thyroid Nodules.
Valderrabano P; Khazai L; Thompson ZJ; Otto KJ; Hallanger-Johnson JE; Chung CH; Centeno BA; McIver B
JAMA Otolaryngol Head Neck Surg; 2018 Sep; 144(9):788-795. PubMed ID: 30027226
[TBL] [Abstract][Full Text] [Related]
11. Correlation Between Histological Diagnosis and Mutational Panel Testing of Thyroid Nodules: A Two-Year Institutional Experience.
Shrestha RT; Evasovich MR; Amin K; Radulescu A; Sanghvi TS; Nelson AC; Shahi M; Burmeister LA
Thyroid; 2016 Aug; 26(8):1068-76. PubMed ID: 27283257
[TBL] [Abstract][Full Text] [Related]
12. The diagnostic accuracy of ultrasound-guided fine-needle aspiration biopsy and the sonographic differences between benign and malignant thyroid nodules 3 cm or larger.
Yoon JH; Kwak JY; Moon HJ; Kim MJ; Kim EK
Thyroid; 2011 Sep; 21(9):993-1000. PubMed ID: 21834673
[TBL] [Abstract][Full Text] [Related]
13. Impact of Afirma gene expression classifier on cytopathology diagnosis and rate of thyroidectomy.
Sacks WL; Bose S; Zumsteg ZS; Wong R; Shiao SL; Braunstein GD; Ho AS
Cancer Cytopathol; 2016 Oct; 124(10):722-728. PubMed ID: 27347838
[TBL] [Abstract][Full Text] [Related]
14. Role of surgeon-performed ultrasound in predicting malignancy in patients with indeterminate thyroid nodules.
Méndez W; Rodgers SE; Lew JI; Montano R; Solórzano CC
Ann Surg Oncol; 2008 Sep; 15(9):2487-92. PubMed ID: 18622644
[TBL] [Abstract][Full Text] [Related]
15. Thyroid Nodule Size at Ultrasound as a Predictor of Malignancy and Final Pathologic Size.
Cavallo A; Johnson DN; White MG; Siddiqui S; Antic T; Mathew M; Grogan RH; Angelos P; Kaplan EL; Cipriani NA
Thyroid; 2017 May; 27(5):641-650. PubMed ID: 28052718
[TBL] [Abstract][Full Text] [Related]
16. Intraoperative pathologic examination in the era of molecular testing for differentiated thyroid cancer.
McCoy KL; Carty SE; Armstrong MJ; Seethala RR; Ohori NP; Kabaker AS; Stang MT; Hodak SP; Nikiforov YE; Yip L
J Am Coll Surg; 2012 Oct; 215(4):546-54. PubMed ID: 22766226
[TBL] [Abstract][Full Text] [Related]
17. Bethesda Category III, IV, and V Thyroid Nodules: Can Nodule Size Help Predict Malignancy?
Kiernan CM; Solórzano CC
J Am Coll Surg; 2017 Jul; 225(1):77-82. PubMed ID: 28223197
[TBL] [Abstract][Full Text] [Related]
18. Underestimated risk of cancer in solitary thyroid nodules ≥3 cm reported as benign.
Bakkar S; Poma AM; Corsini C; Miccoli M; Ambrosini CE; Miccoli P
Langenbecks Arch Surg; 2017 Nov; 402(7):1089-1094. PubMed ID: 28689321
[TBL] [Abstract][Full Text] [Related]
19. Thyroid Ultrasound-Guided Fine-Needle Aspiration Cytology Results: Observed Increase in Indeterminate Rate over the Past Decade.
Manning AM; Yang H; Falciglia M; Mark JR; Steward DL
Otolaryngol Head Neck Surg; 2017 Apr; 156(4):611-615. PubMed ID: 28118554
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of ThyroSeq v2 performance in thyroid nodules with indeterminate cytology.
Valderrabano P; Khazai L; Leon ME; Thompson ZJ; Ma Z; Chung CH; Hallanger-Johnson JE; Otto KJ; Rogers KD; Centeno BA; McIver B
Endocr Relat Cancer; 2017 Mar; 24(3):127-136. PubMed ID: 28104680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
